Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage

Neurosurgery

Volumn 72, Issue 3, 2013, Pages 367-375

  Muroi, Carl ^a,b,c   Hugelshofer, Michael ^a   Seule, Martin ^a   Tastan, Ilhan ^a   Fujioka, Masayuki ^b   Mishima, Kenichi ^b   Keller, Emanuela ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b FUKUOKA UNIVERSITY   (Japan)

^c Kantonsspital Aarau ^*  (Switzerland)

Author keywords

Aneurysmal subarachnoid hemorrhage; Delayed ischemic neurological deficit; Interleukin 6; Procalcitonin; Systemic inflammatory response

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ADULT; ARTICLE; CONTROLLED STUDY; DELAYED ISCHEMIC NEUROLOGICAL DEFICIT; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; INDUCED HYPOTHERMIA; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARAMETERS; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CALCITONIN; CEREBRAL ANGIOGRAPHY; CONFIDENCE INTERVALS; ENDPOINT DETERMINATION; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; HYPOTHERMIA, INDUCED; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; ODDS RATIO; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SAMPLE SIZE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84874381633     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31828048ce     Document Type: Article

References (28)

1. Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70(4):534-537.
2. Sarrafzadeh A, Schlenk F, Gericke C, Vajkoczy P. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010; 13(3):339-346.
3. Nakura T, Osuka K, Inukai T, Takagi T, Takayasu M. Soluble gp130 regulates interleukin-6 in cerebrospinal fluid after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2011;82(9):952-954.
4. Muroi C, Seule M, Sikorski C, Dent W, Keller E. Systemic interleukin-6 levels reflect illness course and prognosis of patients with spontaneous nonaneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:77-80.
5. Muroi C, Bellut D, Coluccia D, Mink S, Fujioka M, Keller E. Systemic interleukin-6 concentrations in patients with perimesencephalic non-aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2011;18(12):1626-1629.
6. Naredi S, Lambert G, Friberg P, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med. 2006;32 (12):1955-1961.
7. Muroi C, Frei K, El Beltagy M, Cesnulis E, Yonekawa Y, Keller E. Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20(3):193-198.
8. Spallone A, Acqui M, Pastore FS, Guidetti B. Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surg Neurol. 1987;27(3):253-258.
9. Weir B, Disney L, Grace M, Roberts P. Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery. 1989; 25(2):161-165.
10. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke. 2001;32(9):1989-1993.
11. Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care. 2008;8 (3):404-412.
12. Tam AK, Ilodigwe D, Mocco J, et al. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database. Neurocrit Care. 2010;13(2):182-189.
13. Seule MA, Muroi C, Mink S, Yonekawa Y, Keller E. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery. 2009;64(1):86-92.
14. Lerch C, Yonekawa Y, Muroi C, Bjeljac M, Keller E. Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(2):85-92.
15. Keller E, Krayenbuhl N, Bjeljac M, Yonekawa Y. Cerebral vasospasm: results of a structured multimodal treatment. Acta Neurochir Suppl. 2005;94:65-73.
16. Broessner G, Beer R, Lackner P, et al. Prophylactic, endovascularly based, longterm normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke. 2009;40(12):e657-e665.
17. Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618-625.
18. Oconnor E, Venkatesh B, Mashongonyika C, Lipman J, Hall J, Thomas P. Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care. 2004; 32(4):465-470.
19. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamua M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 2005;29(4):169-175.
20. Aibiki M, Maekawa S, Ogura S, Kinoshita Y, Kawai N, Yokono S. Effect of moderate hypothermia on systemic and internal jugular plasma IL-6 levels after traumatic brain injury in humans. J Neurotrauma. 1999;16(3):225-232.
21. Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and-independent effects. Stroke. 2011;42(4):924-929.
22. Rothoerl RD, Axmann C, Pina AL, Woertgen C, Brawanski A. Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2006;18(1):68-72.
23. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40(3):994-1025.
24. Dimopoulou I, Orfanos S, Kotanidou A, et al. Plasma pro-and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine. 2008;41(3):263-267.
25. Hayashida H, Kaneko T, Kasaoka S, et al. Comparison of the predictability of neurological outcome by serum procalcitonin and glial fibrillary acidic protein in postcardiac-arrest patients. Neurocrit Care. 2010;12(2):252-257.
26. Juvela S, Kuhmonen J, Siironen J. C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2012;154(3):397-404.
27. Romero FR, Bertolini Ede F, Figueiredo EG, Teixeira MJ. Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage. Arq Neuropsiquiatr. 2012;70(3):202-205.
28. McGirt MJ, Mavropoulos JC, McGirt LY, et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003; 98(6):1222-1226.